Frostproof Family Health Family Medicine Medicare: Medicare Enrolled Practice Location: 200 S Scenic Hwy, Frostproof, FL 33843 Phone: 863-546-6384 |
Jarquin Family Practice Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 N Scenic Hwy, Frostproof, FL 33843 Phone: 863-635-4100 Fax: 863-635-4499 |
Central Florida Health Care Frostproof Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 109 W Wall Street, Frostproof, FL 33843 Phone: 863-635-4891 Fax: 863-635-3545 |
Frost Proof Pharmacy Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 109 W Wall St, Frostproof, FL 33843 Phone: 866-234-8534 |
Alvaro J Jarquin Md Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 N Scenic Hwy #300, Frostproof, FL 33843 Phone: 863-635-4100 Fax: 863-635-4499 |
News Archive
The effort to drag the health-care industry into the technology age trudges onward, and it's still not clear whether the nation's 500,000 to 600,000 physicians will successfully make the journey. That's the finding from a number of health-care industry officials charged with pulling the medical profession into the 21st Century when it comes to managing patient records as well as automating the back-office operations of hospitals and clinics.
While some Mexican immigrants give positive accounts about migrating to and living in the United States, their health status tells a different story.
Xiaocheng Jiang, assistant professor of biomedical engineering in the School of Engineering at Tufts University, has been awarded an early-career award from the Air Force Office of Scientific Research for his work developing graphene-based microfluidics for ultra-high-resolution, dynamic bio-imaging.
PCL Alverno (Hammond, Ind.), recipient of the prestigious ADVANCE Laboratory of the Year award for 2016, will share its strategies for implementing a culture of continuous improvement and lab efficiency at the 10th Anniversary Lab Quality Confab, held October 18-19, 2016, in New Orleans.
Shire plc , the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. REPLAGAL first received marketing authorization in the European Union in 2001, and is approved for the treatment of Fabry disease in 45 countries.
› Verified 2 days ago